C
Privia Health Group, Inc. PRVA
$23.83 $0.451.93%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 3/3/2025Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to C- from D+ on 3/3/2025 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 125.61% from $33.15M to $74.8M, total revenue increased 5.25% from $437.92M to $460.9M, and earnings per share increased from $0.0295 to $0.0299.
D
Sell 10/10/2024Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D+ from D on 10/10/2024 due to an increase in the volatility index and valuation index.
D
Sell 9/25/2024Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to D from D+ on 9/25/2024 due to a decline in the volatility index.
D
Sell 9/9/2024Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D+ from D on 9/9/2024 due to an increase in the volatility index and efficiency index. Net income increased 16.19% from $2.98M to $3.47M, and total capital increased 3.18% from $630.34M to $650.37M.
D
Sell 11/8/2023Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to D from D+ on 11/8/2023 due to a decline in the volatility index, efficiency index and solvency index. Net income declined 22.42% from $7.27M to $5.64M, and the quick ratio declined from 1.78 to 1.73.
D
Sell 7/24/2023Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D+ from D on 7/24/2023 due to an increase in the volatility index.
D
Sell 5/23/2023Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to D from D+ on 5/23/2023 due to a decline in the total return index and volatility index.
D
Sell 5/8/2023Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D+ from D on 5/8/2023 due to an increase in the total return index and volatility index.
D
Sell 5/5/2023Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D from E+ on 5/5/2023 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 6.93% from $530.55M to $567.33M.
E
Sell 3/14/2023Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index and solvency index.
D
Sell 2/9/2023Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D from E+ on 02/09/2023.
E
Sell 2/8/2023Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to E+ from D on 2/8/2023 due to a large decline in the efficiency index, valuation index and solvency index. The quick ratio declined from 1.91 to 1.85.
D
Sell 4/18/2022Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D from D- on 4/18/2022 due to an increase in the total return index and volatility index.
D
Sell 3/25/2022Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to D- from D on 3/25/2022 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 119.66% from $62.65M to -$12.32M, EBIT declined 51.04% from -$12.81M to -$19.35M, and earnings per share declined from -$0.0861 to -$0.1119.
D
Sell 11/10/2021Upgraded
Privia Health Group, Inc. (PRVA) was upgraded to D from D- on 11/10/2021 due to a major increase in the growth index, solvency index and volatility index. Operating cash flow increased 769.79% from $7.2M to $62.65M, earnings per share increased from -$1.6793 to -$0.0861, and EBIT increased 93.37% from -$193.19M to -$12.81M.
D
Sell 10/22/2021Downgrade
Privia Health Group, Inc. (PRVA) was downgraded to D- from D on 10/22/2021 due to a major decline in the volatility index and total return index.
D
Sell 8/11/2021None
Privia Health Group, Inc. (PRVA) was downgraded to D from U on 08/11/2021.
Weiss Ratings